Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 4 1

Status

Terminated 3Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 7Other hematologic neoplasm 5CNS 5Sarcoma 4Gastrointestinal 4Classical hematology 4Tumor-Agnostic 3Gynecologic 3Genitourinary 3Head & Neck 2Dermatologic 2Myeloid 1Endocrine 1

Conditions

Bone Neoplasms 2Sarcoma 1Osteosarcoma 1Hemorrhage 1

Interventions

Radiotherapy 220Doxorubicin 210Cyclophosphamide 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 80Irinotecan 79pembrolizumab 75Radiation 69Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Peripheral Blood Stem Cell Transplantation 57Surgical Procedures, Operative 56Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Tranexamic Acid × Sarcoma × Clear all
NCT04347122 2025-05-21

Tranexamic Acid in Radical Resection and Endoprosthetic Reconstruction

University of Kansas Medical Center

Phase 4 Terminated
12 enrolled 6 charts
Sarcoma

Sarcoma

NCT04410042 2024-12-20

Tranexamic Acid Use to Reduce Blood Transfusion in Pediatric Cancer Patients Undergoing Limb Salvage Procedure

St. Jude Children's Research Hospital

Phase 3 Terminated
15 enrolled 13 charts
Sarcoma

Bone Neoplasms

NCT05024253 2024-02-07

Perioperative Use of Tranexamic (TXA) in Bone Tumor Surgery Will Change in Blood Loss and Transfusion Requirements.

Children's Cancer Hospital Egypt 57357

Phase 3 Completed
48 enrolled
Sarcoma

Osteosarcoma

NCT02153593 2016-09-20

TRANEXTUM

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Phase 3 Terminated
56 enrolled
Sarcoma

Bone Neoplasms, Hemorrhage

Data powered by HemOnc (CC BY 4.0) Colophon âš¡